Current Report Filing (8-k)
09 Febrero 2018 - 3:14PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): February 9, 2018 (February 8, 2018)
ALLERGAN PLC
(Exact
Name of Registrant as Specified in Charter)
|
|
|
|
|
Ireland
|
|
001-36867
|
|
98-1114402
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS Employer
Identification No.)
|
Clonshaugh Business and Technology Park
Coolock, Dublin, D17 E400, Ireland
(Address of Principal Executive Offices)
(862)
261-7000
(Registrants telephone number, including area code)
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions (
see
General Instruction A.2. below):
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c)
|
Indicate by check mark whether the registrant is an emerging growth company as defined
in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§240.12b-2
of this
chapter). ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
On February 8, 2018, the Board of Directors (the Board)
of Allergan plc (the Company) set a record date of March 6, 2018 for participation in the Companys 2018 Annual General Meeting of Shareholders (the 2018 AGM). Only those shareholders of the Company who are
shareholders of record at the close of business on March 6, 2018 will be entitled to receive notice of, and to vote, at the 2018 AGM. The Board also set the date of the Companys 2018 AGM as May 2, 2018.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
|
|
|
Dated: February 9, 2018
|
|
|
|
Allergan plc
|
|
|
|
|
|
|
|
|
By:
|
|
/s/ A. Robert D. Bailey
|
|
|
|
|
|
|
A. Robert D. Bailey
|
|
|
|
|
|
|
Chief Legal Officer and Corporate Secretary
|
Allergan Plc Prfd A (NYSE:AGNPA)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Allergan Plc Prfd A (NYSE:AGNPA)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Allergan Plc Prfd A (New York Stock Exchange): 0 recent articles
Más de Allergan Plc Artículos de Noticias